PubRank

Alzheimer's & dementia (Amsterdam, Netherlands) (Alzheimers Dement (Amst))

Journal PubWeight™ 131.00‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Selective familiarity deficits in otherwise cognitively intact aging individuals with genetic risk for Alzheimer's disease. 2015 1.03
2 THE QUICK DEMENTIA RATING SYSTEM (QDRS): A RAPID DEMENTIA STAGING TOOL. 2015 1.02
3 Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile. 2016 1.02
4 Consensus guidelines for lumbar puncture in patients with neurological diseases. 2017 0.92
5 Retinal microvascular network attenuation in Alzheimer's disease. 2015 0.90
6 Revolutionizing Alzheimer's disease and clinical trials through biomarkers. 2015 0.90
7 Mild Cognitive Impairment and Dementia Prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS). 2016 0.90
8 IMPROVING THE CLINICAL DETECTION OF LEWY BODY DEMENTIA WITH THE LEWY BODY COMPOSITE RISK SCORE. 2015 0.89
9 Cognitive performance before and after the onset of subjective cognitive decline in old age. 2015 0.88
10 Plasma phospholipids and prevalence of mild cognitive impairment and/or dementia in the ARIC Neurocognitive Study (ARIC-NCS). 2016 0.86
11 Thrombopoietin is associated with δ's intercept, and only in Non-Hispanic Whites. 2016 0.86
12 Blood protein predictors of brain amyloid for enrichment in clinical trials? 2015 0.86
13 Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging. 2015 0.85
14 A systematic review and meta-analysis of retinal nerve fiber layer change in dementia, using optical coherence tomography. 2015 0.84
15 Computer mouse movement patterns: A potential marker of mild cognitive impairment. 2015 0.84
16 Association between air pollutants and dementia risk in the elderly. 2015 0.83
17 Concordance of the Montreal cognitive assessment with standard neuropsychological measures. 2015 0.83
18 Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges. 2015 0.83
19 Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite score. 2015 0.83
20 Intracranial Arterial 4D-Flow is Associated with Metrics of Brain Health and Alzheimer's Disease. 2015 0.82
21 Practice effects due to serial cognitive assessment: Implications for preclinical Alzheimer's disease randomized controlled trials. 2015 0.82
22 The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer's disease and mild cognitive impairment. 2015 0.82
23 Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood-based biomarkers. 2016 0.82
24 A systematic review and meta-analysis of (18)F-labeled amyloid imaging in Alzheimer's disease. 2015 0.81
25 Predicting progression from mild cognitive impairment to Alzheimer's disease using longitudinal callosal atrophy. 2016 0.81
26 Plasma sphingolipid changes with autopsy-confirmed Lewy Body or Alzheimer's pathology. 2016 0.81
27 Repeated systemic inflammation was associated with cognitive deficits in older Britons. 2015 0.81
28 Subjective memory complaints, cortical thinning, and cognitive dysfunction in middle-aged adults at risk for AD. 2015 0.81
29 Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes. 2015 0.81
30 Physiological phenotyping of dementias using emotional sounds. 2015 0.81
31 Alzheimer's Genetic Risk Intensifies Neurocognitive Slowing Associated with Diabetes in Non-Demented Older Adults. 2015 0.81
32 Automatic speech analysis for the assessment of patients with predementia and Alzheimer's disease. 2015 0.80
33 Response to editor to the comment by Bastin and Besson (2016) to our article entitled "Selective familiarity deficits in otherwise cognitively intact aging individuals with genetic risk for Alzheimer's disease". 2016 0.80
34 Prediction of Alzheimer's disease pathophysiology based on cortical thickness patterns. 2015 0.80
35 Cerebral atrophy in mild cognitive impairment: A systematic review with meta-analysis. 2015 0.80
36 Development of a subjective cognitive decline questionnaire using item response theory: a pilot study. 2015 0.80
37 Educational inequalities in aging-related declines in fluid cognition and the onset of cognitive pathology. 2015 0.79
38 Cerebrospinal fluid ratios with Aβ42 predict preclinical brain β-amyloid accumulation. 2016 0.79
39 Rates of formal diagnosis of dementia in primary care: The effect of screening. 2015 0.79
40 Periodontal disease's contribution to Alzheimer's disease progression in Down syndrome. 2016 0.79
41 Amyloid burden, cortical thickness, and cognitive function in the Wisconsin Registry for Alzheimer's Prevention. 2015 0.79
42 Plasma BDNF levels associate with Pittsburgh compound B binding in the brain. 2015 0.79
43 Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer's disease. 2015 0.79
44 Assessing risk for preclinical β-amyloid pathology with APOE, cognitive, and demographic information. 2016 0.79
45 Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics. 2016 0.78
46 Random forest to differentiate dementia with Lewy bodies from Alzheimer's disease. 2016 0.78
47 An individual with human immunodeficiency virus, dementia, and central nervous system amyloid deposition. 2016 0.78
48 Hippocampal subfield surface deformity in non-semantic primary progressive aphasia. 2015 0.78
49 The CAIDE Dementia Risk Score App: The development of an evidence-based mobile application to predict the risk of dementia. 2015 0.78
50 Discriminative and prognostic potential of cerebrospinal fluid phosphoTau/tau ratio and neurofilaments for frontotemporal dementia subtypes. 2015 0.78
Next 50